Composite Repair Using Silane Coupling Agent
Launched by CAIRO UNIVERSITY · Apr 29, 2024
Trial Information
Current as of June 08, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a method to improve the repair of dental fillings, specifically looking at a special substance called a silane coupling agent. This agent can help bond materials better when fixing damaged areas of teeth that have issues like discoloration or sensitivity. Researchers want to see if applying this agent separately helps the repaired fillings last longer compared to using it in special adhesives. The study will evaluate the effectiveness of these repairs over the course of a year.
To be eligible for this trial, participants should be between 18 and 45 years old and have healthy teeth with small defects in their dental fillings that were placed 12 to 24 months ago. It's important that they maintain good oral hygiene and are likely to return for follow-up visits. However, individuals with high risk for cavities, poor gum health, or certain other dental issues would not qualify. Participants can expect to have their dental repairs assessed during the study, and they will be contributing to important research that could improve dental care for many people.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Participants Inclusion:
- • Patients aging (18-45). Patients with a high level of oral hygiene. Patients with good likelihood of recall availability. - Teeth Inclusion: The restorations were first placed 12 to 24 months ago. Teeth with healthy remaining tooth structure. Posterior restorations with approximately 3mm in size occlusal marginal defect. Asymptomatic teeth before repair.
- Exclusion Criteria:
- * Participants Exclusion:
- • Patient with high caries risk Patient with poor periodontal health. Heavy bruxism habits. Pregnant or lactating females.
- • -Teeth Exclusion: The restorations with large defects The restorations in the third molars Last experience with allergic reactions against any components of the used materials.
- • Patients receiving orthodontic treatment
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported